<VariationArchive VariationID="2169622" VariationName="NM_001283009.2(RTEL1):c.3559_3562del (p.Gln1187fs)" VariationType="Deletion" Accession="VCV002169622" Version="4" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="2" DateLastUpdated="2024-06-17" DateCreated="2023-02-08" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1899645" VariationID="2169622">
      <GeneList>
        <Gene Symbol="RTEL1" FullName="regulator of telomere elongation helicase 1" GeneID="51750" HGNC_ID="HGNC:15888" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>20q13.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="63657810" stop="63696253" display_start="63657810" display_stop="63696253" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="62289162" stop="62327605" display_start="62289162" display_stop="62327605" Strand="+" />
          </Location>
          <OMIM>608833</OMIM>
        </Gene>
        <Gene Symbol="RTEL1-TNFRSF6B" FullName="RTEL1-TNFRSF6B readthrough (NMD candidate)" GeneID="100533107" HGNC_ID="HGNC:44095" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>20q13.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="63657810" stop="63698698" display_start="63657810" display_stop="63698698" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_001283009.2(RTEL1):c.3559_3562del (p.Gln1187fs)</Name>
      <CanonicalSPDI>NC_000020.11:63695383:AGACAGA:AGA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>20q13.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="63695384" stop="63695387" display_start="63695384" display_stop="63695387" variantLength="4" positionVCF="63695383" referenceAlleleVCF="TAGAC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="62326737" stop="62326740" display_start="62326737" display_stop="62326740" variantLength="4" positionVCF="62326736" referenceAlleleVCF="TAGAC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>Q1187fs</ProteinChange>
      <ProteinChange>Q964fs</ProteinChange>
      <ProteinChange>Q1211fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.10" sequenceAccession="NC_000020" sequenceVersion="10" change="g.62326740_62326743del" Assembly="GRCh37">
            <Expression>NC_000020.10:g.62326740_62326743del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.11" sequenceAccession="NC_000020" sequenceVersion="11" change="g.63695387_63695390del" Assembly="GRCh38">
            <Expression>NC_000020.11:g.63695387_63695390del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033901.1" sequenceAccession="NG_033901" sequenceVersion="1" change="g.42578_42581del">
            <Expression>NG_033901.1:g.42578_42581del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_046961.1" sequenceAccession="NG_046961" sequenceVersion="1" change="g.3737_3740del">
            <Expression>NG_046961.1:g.3737_3740del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_037882.1" sequenceAccession="NR_037882" sequenceVersion="1" change="n.4386_4389del">
            <Expression>NR_037882.1:n.4386_4389del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001283009.2" sequenceAccession="NM_001283009" sequenceVersion="2" change="c.3559_3562del" MANESelect="true">
            <Expression>NM_001283009.2:c.3559_3562del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001269938.1" sequenceAccession="NP_001269938" sequenceVersion="1" change="p.Gln1187fs">
            <Expression>NP_001269938.1:p.Gln1187fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001283010.1" sequenceAccession="NM_001283010" sequenceVersion="1" change="c.2890_2893del">
            <Expression>NM_001283010.1:c.2890_2893del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001269939.1" sequenceAccession="NP_001269939" sequenceVersion="1" change="p.Gln964fs">
            <Expression>NP_001269939.1:p.Gln964fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_016434.4" sequenceAccession="NM_016434" sequenceVersion="4" change="c.3559_3562del">
            <Expression>NM_016434.4:c.3559_3562del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_057518.1" sequenceAccession="NP_057518" sequenceVersion="1" change="p.Gln1187fs">
            <Expression>NP_057518.1:p.Gln1187fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_032957.5" sequenceAccession="NM_032957" sequenceVersion="5" change="c.3631_3634del">
            <Expression>NM_032957.5:c.3631_3634del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_116575.3" sequenceAccession="NP_116575" sequenceVersion="3" change="p.Gln1211fs">
            <Expression>NP_116575.3:p.Gln1211fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1149" sequenceAccession="LRG_1149">
            <Expression>LRG_1149:g.42578_42581del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1149t2" sequenceAccession="LRG_1149t2">
            <Expression>LRG_1149t2:c.3559_3562del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1149p2" sequenceAccession="LRG_1149p2" change="p.Gln1187fs">
            <Expression>LRG_1149p2:p.Gln1187fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1149t3" sequenceAccession="LRG_1149t3">
            <Expression>LRG_1149t3:c.3559_3562del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1149p3" sequenceAccession="LRG_1149p3" change="p.Gln1187fs">
            <Expression>LRG_1149p3:p.Gln1187fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1149t1" sequenceAccession="LRG_1149t1">
            <Expression>LRG_1149t1:c.3631_3634del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1149p1" sequenceAccession="LRG_1149p1" change="p.Gln1211fs">
            <Expression>LRG_1149p1:p.Gln1211fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001283009.2(RTEL1):c.3559_3562del (p.Gln1187fs) AND multiple conditions" Accession="RCV003084921" Version="3">
        <ClassifiedConditionList TraitSetID="36999">
          <ClassifiedCondition DB="MedGen" ID="C3554656">Dyskeratosis congenita, autosomal recessive 5</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C4225346">Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001283009.2(RTEL1):c.3559_3562del (p.Gln1187fs) AND Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3" Accession="RCV004560041" Version="1">
        <ClassifiedConditionList TraitSetID="21542">
          <ClassifiedCondition DB="MedGen" ID="C4225346">Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-13" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001283009.2(RTEL1):c.3559_3562del (p.Gln1187fs) AND Dyskeratosis congenita, autosomal recessive 5" Accession="RCV004572782" Version="1">
        <ClassifiedConditionList TraitSetID="9567">
          <ClassifiedCondition DB="MedGen" ID="C3554656">Dyskeratosis congenita, autosomal recessive 5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-04" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-13" NumberOfSubmissions="3" NumberOfSubmitters="2" DateCreated="2023-02-08" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">23453664</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25047097</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25099625</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25620558</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26025130</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30523160</ID>
        </Citation>
        <DescriptionHistory Dated="2024-06-06">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="21542" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33358" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 3</ElementValue>
                <XRef Type="MIM" ID="616373" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608833.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608833.0020" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608833.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608833.0019" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608833.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608833.0017" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608833.0018" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3</ElementValue>
                <XRef ID="MONDO:0014613" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PFBMFT3</ElementValue>
                <XRef Type="MIM" ID="616373" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Dyskeratosis congenita and related telomere biology disorders (DC/TBD) are caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum of telomere biology disorders is broad and includes individuals with classic dyskeratosis congenita (DC) as well as those with very short telomeres and an isolated physical finding. Classic DC is characterized by a triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia, although this may not be present in all individuals. People with DC/TBD are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome or acute myelogenous leukemia, solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), taurodontism, liver disease, gastrointestinal telangiectasias, and avascular necrosis of the hips or shoulders. Although most persons with DC/TBD have normal psychomotor development and normal neurologic function, significant developmental delay is present in both forms; additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome and Coats plus syndrome). Onset and progression of manifestations of DC/TBD vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.</Attribute>
                <XRef ID="NBK22301" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16098" />
                <XRef ID="16098" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301408</ID>
                <ID Source="BookShelf">NBK1230</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301779</ID>
                <ID Source="BookShelf">NBK22301</ID>
              </Citation>
              <XRef ID="2032" DB="Orphanet" />
              <XRef ID="C4225346" DB="MedGen" />
              <XRef ID="MONDO:0014613" DB="MONDO" />
              <XRef Type="MIM" ID="616373" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="36999" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33358" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 3</ElementValue>
                <XRef Type="MIM" ID="616373" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608833.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608833.0020" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608833.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608833.0019" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608833.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608833.0017" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608833.0018" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3</ElementValue>
                <XRef ID="MONDO:0014613" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PFBMFT3</ElementValue>
                <XRef Type="MIM" ID="616373" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Dyskeratosis congenita and related telomere biology disorders (DC/TBD) are caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum of telomere biology disorders is broad and includes individuals with classic dyskeratosis congenita (DC) as well as those with very short telomeres and an isolated physical finding. Classic DC is characterized by a triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia, although this may not be present in all individuals. People with DC/TBD are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome or acute myelogenous leukemia, solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), taurodontism, liver disease, gastrointestinal telangiectasias, and avascular necrosis of the hips or shoulders. Although most persons with DC/TBD have normal psychomotor development and normal neurologic function, significant developmental delay is present in both forms; additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome and Coats plus syndrome). Onset and progression of manifestations of DC/TBD vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.</Attribute>
                <XRef ID="NBK22301" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16098" />
                <XRef ID="16098" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301408</ID>
                <ID Source="BookShelf">NBK1230</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301779</ID>
                <ID Source="BookShelf">NBK22301</ID>
              </Citation>
              <XRef ID="2032" DB="Orphanet" />
              <XRef ID="C4225346" DB="MedGen" />
              <XRef ID="MONDO:0014613" DB="MONDO" />
              <XRef Type="MIM" ID="616373" DB="OMIM" />
            </Trait>
            <Trait ID="17752" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Dyskeratosis congenita, autosomal recessive 5</ElementValue>
                <XRef ID="MONDO:0014076" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DKCB5</ElementValue>
                <XRef Type="MIM" ID="615190" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Dyskeratosis congenita and related telomere biology disorders (DC/TBD) are caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum of telomere biology disorders is broad and includes individuals with classic dyskeratosis congenita (DC) as well as those with very short telomeres and an isolated physical finding. Classic DC is characterized by a triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia, although this may not be present in all individuals. People with DC/TBD are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome or acute myelogenous leukemia, solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), taurodontism, liver disease, gastrointestinal telangiectasias, and avascular necrosis of the hips or shoulders. Although most persons with DC/TBD have normal psychomotor development and normal neurologic function, significant developmental delay is present in both forms; additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome and Coats plus syndrome). Onset and progression of manifestations of DC/TBD vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.</Attribute>
                <XRef ID="NBK22301" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15917" />
                <XRef ID="15917" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301779</ID>
                <ID Source="BookShelf">NBK22301</ID>
              </Citation>
              <XRef ID="C3554656" DB="MedGen" />
              <XRef ID="MONDO:0014076" DB="MONDO" />
              <XRef Type="MIM" ID="615190" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9567" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17752" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Dyskeratosis congenita, autosomal recessive 5</ElementValue>
                <XRef ID="MONDO:0014076" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DKCB5</ElementValue>
                <XRef Type="MIM" ID="615190" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Dyskeratosis congenita and related telomere biology disorders (DC/TBD) are caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum of telomere biology disorders is broad and includes individuals with classic dyskeratosis congenita (DC) as well as those with very short telomeres and an isolated physical finding. Classic DC is characterized by a triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia, although this may not be present in all individuals. People with DC/TBD are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome or acute myelogenous leukemia, solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), taurodontism, liver disease, gastrointestinal telangiectasias, and avascular necrosis of the hips or shoulders. Although most persons with DC/TBD have normal psychomotor development and normal neurologic function, significant developmental delay is present in both forms; additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome and Coats plus syndrome). Onset and progression of manifestations of DC/TBD vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.</Attribute>
                <XRef ID="NBK22301" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15917" />
                <XRef ID="15917" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301779</ID>
                <ID Source="BookShelf">NBK22301</ID>
              </Citation>
              <XRef ID="C3554656" DB="MedGen" />
              <XRef ID="MONDO:0014076" DB="MONDO" />
              <XRef Type="MIM" ID="615190" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="6173495" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="7130458|MedGen:C3554656;C4225346" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003483329" DateUpdated="2024-02-28" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">30523160</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23453664</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24009516</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25047097</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25099625</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25620558</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26025130</ID>
          </Citation>
          <Comment>This sequence change results in a frameshift in the RTEL1 gene (p.Gln1187Glyfs*176). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 114 amino acid(s) of the RTEL1 protein and extend the protein by 61 additional amino acid residues. This variant is not present in population databases (gnomAD no frequency). This frameshift has been observed in individual(s) with pulmonary fibrosis (PMID: 30523160). ClinVar contains an entry for this variant (Variation ID: 2169622). This variant disrupts a region of the RTEL1 protein in which other variant(s) (p.Arg1264) have been determined to be pathogenic (PMID: 23453664, 24009516, 25047097, 25099625, 25620558, 26025130). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RTEL1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000020.10:g.62326737_62326740del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3554656" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4225346" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9799168" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2024-06-09">
        <ClinVarSubmissionID localKey="NM_032957.5:c.3631_3634del|OMIM:616373" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005049441" DateUpdated="2024-06-09" DateCreated="2024-06-09" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_032957.5:c.3631_3634del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616373" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>WES_20231129_20240331</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9814062" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2024-06-17">
        <ClinVarSubmissionID localKey="NM_032957.5:c.3631_3634del|OMIM:615190" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005055471" DateUpdated="2024-06-17" DateCreated="2024-06-17" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_032957.5:c.3631_3634del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="615190" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9799168" TraitType="Disease" MappingType="XRef" MappingValue="616373" MappingRef="OMIM">
        <MedGen CUI="C4225346" Name="Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6173495" TraitType="Disease" MappingType="XRef" MappingValue="C3554656" MappingRef="MedGen">
        <MedGen CUI="C3554656" Name="Dyskeratosis congenita, autosomal recessive 5" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9814062" TraitType="Disease" MappingType="XRef" MappingValue="615190" MappingRef="OMIM">
        <MedGen CUI="C3554656" Name="Dyskeratosis congenita, autosomal recessive 5" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6173495" TraitType="Disease" MappingType="XRef" MappingValue="C4225346" MappingRef="MedGen">
        <MedGen CUI="C4225346" Name="Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

